Money, Fiance News, Press Release Distribution
Financial News and Press Release Distribution Services

Submit RSS Feed | About US | Contact Us





Home | Personal Finance News | Submit Press Release
Unlimited Press Release Distribution
Press release distribution service

Money News Media
Bankrate
CNBC
CNNMoney
Finacial Times
FOX Business
Moneynews


Money News Now


USNews
Reuters Money
RSS News Feed
Get your news feed listed here as other news media shown above! Submit RSS News Feed

Personal Finance News Releases

China Vaccine Market & Doses Forecast By Sector & Products (2019 - 2025)

(MoneyNewsWire.Net, December 06, 2019 ) Vaccines are developed to address the public health needs. In China, vaccines are available through the government programmed called “Expanded Program on Immunization” at free for all children up to 14 years of age. However private sector vaccines such as Rabies Vaccine, Influenza Vaccine and Haemophilus Influenza Type B vaccine are also available in China but are usually paid for out-of-pocket as these are neither include in government EPI program nor government health insurance schemes. China Vaccine Market has great potential due to its vast population; so, its market size is projected to cross over US$ 9 Billion by 2025.



China vaccine market is divided into public and private vaccine market. Public market is classified by Category 1 whereas and Private vaccines included in Category 2. Vaccines in the public market are regulated by PRC government and generally given free of cost by provincial CDC whereas private vaccine market is dominating by private vaccine companies. As a result, private vaccines prices are higher. China vaccine market has faced several scandals in past couple of years which certainly hinder the vaccine market growth.



Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=china-vaccine-market-p.php





Renub Research report titled “China Vaccine Market & Doses Forecast By Sector (Private, Public), Disease Type (Meningococcal Meningitis, Pneumococcal, DTP, Ebola, Rabies, Others), Products (MCV4, MPSV4, MCV2-Hib, MCV2, MPSV2 and Men A, PCV13, PPV23, Others), Company (Sinopharm Group, Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd, Chongqing Zhifei Biological Products Co Ltd, Hualan Biological Engineering Inc, Liaoning Chengda Co Ltd, Walvax Biotechnology Co Ltd)” provides a complete analysis of China Vaccine Market.





Sectors – Vaccine Market & Doses in China



• Public

• Private





Disease Type Market - Meningococcal Meningitis, Pneumococcal and DTP Vaccine Market has significant Market Share in China Vaccine Market



On the basis of disease type, Meningococcal meningitis, Pneumococcal and DTP Vaccine market is expected to control major portion of China vaccine market. Vaccine market in China is segmented into Meningococcal meningitis, Pneumococcal, DTP, Ebola, Rabies & Others.





Products – PCV13 Drives Vaccine Market in China



In terms of products, PCV13 hold the maximum share of the China vaccine market. It is predicted that PCV13 will maintain their leading place during the forecasting period as well. Products included in this report are as follows:



• MCV4

• MPSV4

• MCV2-Hib

• MCV2

• MPSV2 and Men A

• PCV13

• PPV23





Public and Private Vaccine Market & Doses



This report provides the detailed analysis of public and private vaccine market in China. Report also provides private and public vaccine doses in China.





Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=china-vaccine-market-p.php





Company Analysis



All the companies covered in the report has been covered from the following points



• Overview

• Recent Development

• Vaccine Pipeline

• Revenue Analysis





Key Company Covered – China Vaccine Market



• Sinopharm Group (China National Biotec Group Company Limited)

• Sinovac Biotech, Beijing Tiantan Biological Products Corp Ltd

• Chongqing Zhifei Biological Products Co Ltd

• Hualan Biological Engineering Inc

• Liaoning Chengda Co Ltd

• Walvax Biotechnology Co Ltd





If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.





Browse Related Reports:



Global Vaccine Market @ https://www.renub.com/global-vaccines-market-and-forecast-14-vaccines-market-number-of-people-immunized-doses-of-vaccines-administered-1200-p.php



Pediatric Vaccine Market @ https://www.renub.com/pediatric-vaccines-market-doses-immunization-cases-and-forecast-worldwide-analysis-166-p.php





About Us



Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.





Contact Us

Renub Research

Phone: +1-678-302-0700

Email: info@renub.com

Website: www.renub.com

Follow us on LinkedIn: www.linkedin.com/company/renub-research

Renub Research

Rajat Gupta

Market Research, Bus

rajat.gupta@renub.com

Source: EmailWire.Com


Personal Finance News
  • Auto
  • CDs
  • College
  • Credit Cards
  • Insurance
  • Mortgage
  • Mutual Funds
  • Retirement
  • Savings
  • Taxes

  • Money RSS Marketpalce

    Free Finance Magazines Downloads
    Get free publications including magazines, white papers on finance, investments.
    Submit RSS news feed on Finance, Investment.
    Have your feed on news, products or services displayed under this marketpalce. The feed also displayed on a full page and updated daily.



    Money NewsWire is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

    For unlimited press release distribution for $99 per month or $999 per year, call (281) 645-4086 or start posting your press releases online at EmailWire.com.
    Copyright 2009 GroupWeb Media LLC

    GroupWeb Media Network
    AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
    | InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
    Money-NewsWire.Net - Newswire and Press Release service of GroupWeb Media LLC